COMPANY PROFILE | VYDENCE MEDICAL |
A NEW CHAPTER FOR VYDENCE® MEDICAL 38 YEARS OF INNOVATION IN MEDICAL AESTHETICS
Combining powerful multi-platform systems with user-friendly innovation, VYDENCE® Medical is equipping practices worldwide with versatile, compact, and effective tools that deliver measurable results and profitability
V
WENDY LEWIS is Founder/ President of Wendy Lewis & Co Ltd, Global Aesthetics Consultancy since 1997, author of 13 books, and frequent presenter on the international stage. Her first textbook, Aesthetic Clinic Marketing in the Digital Age (CRC Press) debuted a second edition in 2024. email: wl@wendylewisco.com
14
YDENCE® MEDICAL IS BASED IN SÃO CARLOS, BRAZIL, AND HAS expanded its presence globally to be present in over 30 countries. The recent acquisition of VYDENCE® Medical by the MedSystems Group marks a strategic milestone for the company. Their goal is to shape the future of innovation in medical-aesthetic technology. According to Denis Régis, ‘I am honoured to step into the role of CEO at MedSystems Group during this transformative time in our history of more than 38 years. The acquisition of VYDENCE® by the MedSystems Group marks an important milestone in medical-aesthetic technology around the world.’ ‘Backed by the strength of the MedSystems ecosystem, we are now poised to accelerate our innovation roadmap, expand our global footprint, and deliver even more value to our customers, partners, and teams,’ he says. Currently, the company is active in six key markets: Latin America, Europe, the Middle East, Africa, Asia, and, most recently, North America. Under the new management team, they are considering their next opportunities in major markets.
The Brazilian heritage
VYDENCE® Medical is based in São Carlos, Brazil, and has expanded its presence globally. The company is currently present in over 30 markets, including headquarters in Brazil and the United States. This international expansion underscores VYDENCE®’s commitment to delivering advanced laser technologies across diverse markets. VYDENCE® has earned its place as a leader in the development and manufacturing of high-performance medical devices in key markets. Their Etherea MX platform is sold in more than 30 countries worldwide to date. Antônio Olivatto is the Executive Vice President Global at VYDENCE® Medical and is leading the next chapter in the company’s evolution with the MedSystems Group. ‘We pride ourselves on taking care of our partners and will find efficacy, versatility, and
May/June 2025 | prime-journal.com
ZYE ALX®